Cargando…

Antiphospholipid Antibodies in Lupus Nephritis

Lupus nephritis (LN) is a major manifestation of systemic lupus erythematosus (SLE). It remains unclear whether antiphospholipid antibodies (aPL) alter the course of LN. We thus investigated the impact of aPL on short-term and long-term renal outcomes in patients with LN. We assessed levels of aPL c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parodis, Ioannis, Arnaud, Laurent, Gerhardsson, Jakob, Zickert, Agneta, Sundelin, Birgitta, Malmström, Vivianne, Svenungsson, Elisabet, Gunnarsson, Iva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919007/ https://www.ncbi.nlm.nih.gov/pubmed/27336701 http://dx.doi.org/10.1371/journal.pone.0158076

Ejemplares similares

Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy
por: Parodis, Ioannis, et al.
Publicado: (2015)

Histological antiphospholipid-associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up
por: Gerhardsson, Jakob, et al.
Publicado: (2015)

Interferon (IFN)-λ is a potential mediator in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2016)

Role of early repeated renal biopsies in lupus nephritis
por: Zickert, A, et al.
Publicado: (2014)

IL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment
por: Zickert, Agneta, et al.
Publicado: (2015)

Occurrence and localization of FOXP3 + cells in kidney biopsies in lupus nephritis and ANCA-associated vasculitis
por: Zickert, Agneta, et al.
Publicado: (2023)

Urinary aberrations in systemic lupus erythematosus not always indicative of lupus nephritis: a cross-sectional cohort study
por: Karlsson, Linnea, et al.
Publicado: (2023)

Renal expression and serum levels of high mobility group box 1 protein in lupus nephritis
por: Zickert, Agneta, et al.
Publicado: (2012)

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
por: Häyry, Aliisa, et al.
Publicado: (2022)

Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis
por: Parodis, Ioannis, et al.
Publicado: (2019)

Ofatumumab treatment in lupus nephritis patients
por: Haarhaus, Malena Loberg, et al.
Publicado: (2016)

Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: a case–control study
por: Samuelsson, Isak, et al.
Publicado: (2021)

Association of STAT4 Polymorphism with Severe Renal Insufficiency in Lupus Nephritis
por: Bolin, Karin, et al.
Publicado: (2013)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017)

ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus
por: Parodis, Ioannis, et al.
Publicado: (2020)

Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2021)

Serum levels of autoantibodies against C-reactive protein correlate with renal disease activity and response to therapy in lupus nephritis
por: Sjöwall, Christopher, et al.
Publicado: (2009)

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
por: Oke, Vilija, et al.
Publicado: (2019)

Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations
por: Mobarrez, Fariborz, et al.
Publicado: (2016)

Mutations in genes encoding complement inhibitors CD46 and CFH affect the age at nephritis onset in patients with systemic lupus erythematosus
por: Jönsen, Andreas, et al.
Publicado: (2011)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
por: Sohrabian, Azita, et al.
Publicado: (2019)

TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus
por: Idborg, Helena, et al.
Publicado: (2018)

The impact of antiphospholipid antibodies in children with lupus nephritis
por: Al-Mayouf, Sulaiman M., et al.
Publicado: (2015)

Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
por: Martin, Myriam, et al.
Publicado: (2020)

Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with HLA-DRB1*13 and negatively with HLA-DRB1*03 in SLE
por: Elbagir, Sahwa, et al.
Publicado: (2022)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
por: Parodis, Ioannis, et al.
Publicado: (2020)

De novo lupus nephritis during treatment with belimumab
por: Parodis, Ioannis, et al.
Publicado: (2020)

B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)

Urine Galectin-3 binding protein reflects nephritis activity in systemic lupus erythematosus
por: Faustini, Francesca, et al.
Publicado: (2022)

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis
por: Hardt, Uta, et al.
Publicado: (2018)

Genetic Risk Factors in Lupus Nephritis and IgA Nephropathy – No Support of an Overlap
por: Vuong, Mai Tuyet, et al.
Publicado: (2010)

Prediction of prognosis and renal outcome in lupus nephritis
por: Parodis, Ioannis, et al.
Publicado: (2020)

Infection hospitalisation in systemic lupus in Sweden
por: Simard, Julia F, et al.
Publicado: (2021)

Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
por: Hanaoka, Hironari, et al.
Publicado: (2018)

Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis
por: Wilson, Hannah R., et al.
Publicado: (2019)

Plasma exchange for concurrent lupus nephritis and antiphospholipid syndrome
por: Sendzischew, Morgan A., et al.
Publicado: (2014)

Antiphospholipid antibodies in patients with calcific aortic valve stenosis
por: Plunde, Oscar, et al.
Publicado: (2022)

Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
por: Parodis, Ioannis, et al.
Publicado: (2022)

Toll-like receptors revisited; a possible role for TLR1 in lupus nephritis
por: Yavuz, Sule, et al.
Publicado: (2021)

Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature
por: Palazzo, Leonardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_endcqc8k6d8nicn2lm5r0eb146